Nasivin Kids Tartósítószermentes (Oxymetazoline Hydrochloride)

Oxymetazoline nasal spray is indicated for pediatric nasal congestion arising from several common upper‑respiratory conditions.

• Common cold: reduces nasal blockage and improves breathing in children.
• Sinusitis: alleviates mucosal swelling to ease sinus drainage.
• Allergic rhinitis: diminishes congestion caused by allergen‑induced inflammation.

• Oxymetazoline acts as a selective alpha‑adrenergic receptor agonist. By stimulating α1‑ and α2‑adrenergic receptors on the vascular smooth muscle of the nasal mucosa, it induces vasoconstriction, which decreases blood flow, reduces edema, and opens the nasal airway. The localized effect limits systemic absorption, providing rapid decongestion without significant systemic adrenergic activity.

Oxymetazoline nasal spray may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects

• Nasal irritation or burning sensation.
• Sneezing.
• Dryness of the nasal mucosa.
• Mild epistaxis (nosebleed).

Serious or Rare Side Effects

• Persistent nasal congestion (rebound congestion) with prolonged use.
• Hypertension or elevated blood pressure.
• Tachycardia or irregular heart rhythm.
• Severe allergic reaction (anaphylaxis) with rash, swelling, or difficulty breathing.

When using Oxymetazoline nasal spray in children, several safety considerations should be observed.

• Age restriction: use only in children as directed by a healthcare professional.
• Duration limit: do not exceed the recommended treatment period (typically no more than 3 days) to avoid rebound congestion.
• Pre‑existing conditions: avoid in patients with hypertension, cardiovascular disease, hyperthyroidism, or glaucoma unless advised.
• Concomitant medications: consult a physician if using other nasal decongestants or monoamine oxidase inhibitors.
• Pregnancy and lactation: safety not established; use only if clearly needed and prescribed.
• Store at ambient temperature below 25 °C: keep in original packaging, protect from moisture and direct sunlight.

Oxymetazoline may interact with other medicines, requiring caution.

Major Interactions (Avoid)

• Monoamine oxidase inhibitors (MAOIs): may cause hypertensive crisis when combined with oxymetazoline.
• Other topical nasal decongestants: concurrent use can increase risk of severe rebound congestion.

Moderate Interactions (Monitor Closely)

• Systemic sympathomimetic drugs (e.g., pseudoephedrine): may enhance cardiovascular effects.
• Antihypertensive agents: oxymetazoline may reduce their efficacy, requiring blood pressure monitoring.
• Tricyclic antidepressants: potential additive adrenergic activity; monitor for tachycardia.